We are live on ! Find out more
ROIVW

Roivant Sciences Ltd. Warrant

Delisted

ROIVW was delisted on the 1st of September, 2023.

26 hedge funds and large institutions have $37.6M invested in Roivant Sciences Ltd. Warrant in 2023 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 1

50% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 4

13% more funds holding

Funds holding: 2326 (+3)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

11% less capital invested

Capital invested by funds: $42.1M → $37.6M (-$4.52M)

Holders
26
Holders Change
+3
Holders Change %
+13.04%
% of All Funds
0.41%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
4
Increased
6
Reduced
4
Closed
1
Calls
$8.34M
Puts
Net Calls
+$8.34M
Net Calls Change
+$1.51M
Name Holding Trade Value Shares
Change
Change in
Stake
SC
26
Sculptor Capital
New York
$32.2K +$25.6K +13,000 New
Walleye Trading
27
Walleye Trading
New York
$27.5K
TRCT
28
Tower Research Capital (TRC)
New York
$312
ACA
29
Arena Capital Advisors
California
-$87.3K -59,775 Closed

ROIVW Hedge Fund Activity: Q2 2023 in Review

26 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Roivant Sciences Ltd. Warrant (ROIVW) for Q2 2023, worth a combined $37.6M — down 11% from $42.1M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new ROIVW positions and 1 closed out — a net gain of 3 holders — while 6 added to existing stakes and 4 trimmed.

The largest buyer was Fort Baker Capital Management, opening a new position worth an estimated $2.21M. The largest seller was Aristeia Capital, cutting an estimated $1.25M.

  • 26 institutional investors held Roivant Sciences Ltd. Warrant (ROIVW) as of Q2 2023, up from 23 in Q1 2023.
  • Funds reported $37.6M of Roivant Sciences Ltd. Warrant stock for Q2 2023, down 11% quarter-over-quarter.
  • 4 funds opened new Roivant Sciences Ltd. Warrant positions in Q2 2023 and 1 closed out, a net change of +3 holders.
  • The largest Roivant Sciences Ltd. Warrant buyer in Q2 2023 was Fort Baker Capital Management, an estimated $2.21M added.
  • The largest Roivant Sciences Ltd. Warrant seller in Q2 2023 was Aristeia Capital, an estimated $1.25M sold.

Based on aggregated 13F filings for Q2 2023.